STOCK TITAN
  1. Home
  2. Sec-filings
  3. CYBN
  4. [6-K] Cybin Inc. Current Report (Foreign Issuer)

[6-K] Cybin Inc. Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock CYBN logo
Cybin Inc

NYSE:CYBN

CYBN Rankings

#5987 Ranked by Market Cap
N/A Ranked by Dividends

CYBN Latest News

Jul 17, 2025
Cybin Receives UK MHRA Approval to Commence EMBRACE, A Multinational Pivotal Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder
Jul 1, 2025
REPEAT/Cybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible Debentures
Jun 30, 2025
Cybin Reports Fiscal Year 2025 Financial Results and Recent Business Highlights
Jun 30, 2025
Cybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible Debentures
Jun 13, 2025
Cybin Provides Corporate Update and Highlights Positive Regulatory Signals for Psychedelic Therapeutics

CYBN Latest SEC Filings

Jul 14, 2025
[6-K] Cybin Inc. Current Report (Foreign Issuer)
Jul 14, 2025
[SUPPL] Cybin Inc. SEC Filing
Jul 10, 2025
[D] Cybin Inc. SEC Filing
Jul 10, 2025
[6-K] Cybin Inc. Current Report (Foreign Issuer)
Jul 1, 2025
[6-K] Cybin Inc. Current Report (Foreign Issuer)

CYBN Stock Data

175.05M
19.22M
238.24%
41.95%
5.19%
Biotechnology
Healthcare
Link
Canada
Toronto